POP-OUT | CLOSE

An Information Portal to 110790 Biological Macromolecular Structures

 
RIFAMPICIN
 
RFP is found in 7 entries
RFP
  •   Chemical Component Summary   Hide
    Name RIFAMPICIN
    Identifiers (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
    Formula C43 H58 N4 O12
    Molecular Weight 822.94 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key JQXXHWHPUNPDRT-WLSIYKJHSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01045   (Stereoisomeric match)
    Name Rifampicin
    Groups approved
    Description A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
    Synonyms
    • 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv
    • RFP
    • Rifampicina
    • Rifampicinum
    • Rifampin
    Salts Rifampicin sodium
    Brand names
    • Rifadin
    • Rifadin Iv
    • Rifampin
    Affected organism
    • Mycobacteria
    • Mycobacterium tuberculosis
    • Various gram-negative and gram-positive eubacteria
    Indication For the treatment of Tuberculosis and Tuberculosis-related mycobacterial infections.
    Pharmacology Rifampin is an antibiotic that inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. It is bactericidal and has a very broad spectrum of activity against most gram-positive and gram-negative organisms (including Pseudomonas aeruginosa) and specifically Mycobacterium tuberculosis. Because of rapid emergence of resistant bacteria, use is restricted to treatment of mycobacterial infections and a few other indications. Rifampin is well absorbed when taken orally and is distributed widely in body tissues and fluids, including the CSF. It is metabolized in the liver and eliminated in bile and, to a much lesser extent, in urine, but dose adjustments are unnecessary with renal insufficiency.
    Mechanism of action Rifampin acts via the inhibition of DNA-dependent RNA polymerase, leading to a suppression of RNA synthesis and cell death.
    Route of administration
    • intravenous
    • oral
    • oral; oral
    Categories
    • Enzyme Inhibitors
    • Antitubercular Agents
    • Nucleic Acid Synthesis Inhibitors
    • Leprostatic Agents
    • Antibiotics, Antitubercular
    • Antibiotics
    [more]
    ATC-Code J04AB02
    AHFS-Code 08:16.04
    CAS number 13292-46-1
    Targets
    Name Sequence search Pharmacological action Actions
    DNA-directed RNA polymerase subunit beta   Search  yes inhibitor
    Serum albumin   Search  unknown
    Lanosterol 14-alpha demethylase   Search  unknown
    Nuclear receptor subfamily 1 group I member 2   Search  unknown agonist
    Solute carrier organic anion transporter family member 1B1   Search  unknown
    [more]
     
Ligand Image